Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianshu Feng

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Bioorganic & Medicinal Chemistry Letters|May 2, 2025
Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitorScott Throner, Tianshu Feng, Jannik N Andersen, et al.
Molecular Cancer Therapeutics|May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumorsKatherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Molecular Cancer Therapeutics|January 31, 2025
Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination DeficiencyAntoine Simoneau, Charlotte B Pratt, Hsin-Jung Wu, et al.
Molecular Cancer Therapeutics|January 27, 2025
LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant CancersLauren Catherine M Martires, Leanne G Ahronian, Charlotte B Pratt, et al.
Molecular Cell|February 4, 2014
Optimal translational termination requires C4 lysyl hydroxylation of eRF1Tianshu Feng, Atsushi Yamamoto, Sarah E Wilkins, et al.
Molecular Cancer Therapeutics|October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in CancerAntoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 3, 2022
Associations of Maternal Prenatal Stress and Depressive Symptoms With Childhood Neurobehavioral Outcomes in the ECHO Cohort of the NICHD Fetal Growth Studies: Fetal Growth Velocity as a Potential MediatorVanessa Babineau, Yaneve N Fonge, Emily S Miller, et al.
Nature Chemical Biology|October 30, 2012
Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humansWei Ge, Alexander Wolf, Tianshu Feng, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Bioorganic & Medicinal Chemistry Letters|May 2, 2025
Discovery of TNG-6132, a potent, selective, and orally bioavailable USP1 inhibitorScott Throner, Tianshu Feng, Jannik N Andersen, et al.
Molecular Cancer Therapeutics|May 6, 2025
CRISPR screens identify POLB as a synthetic lethal enhancer of PARP inhibition exclusively in BRCA-mutated tumorsKatherine Lazarides, Justin L Engel, Michele Meseonznik, et al.
Molecular Cancer Therapeutics|January 31, 2025
Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination DeficiencyAntoine Simoneau, Charlotte B Pratt, Hsin-Jung Wu, et al.
Molecular Cancer Therapeutics|January 27, 2025
LIG1 Is a Synthetic Lethal Target in BRCA1 Mutant CancersLauren Catherine M Martires, Leanne G Ahronian, Charlotte B Pratt, et al.
Molecular Cell|February 4, 2014
Optimal translational termination requires C4 lysyl hydroxylation of eRF1Tianshu Feng, Atsushi Yamamoto, Sarah E Wilkins, et al.
Molecular Cancer Therapeutics|October 13, 2022
Ubiquitinated PCNA Drives USP1 Synthetic Lethality in CancerAntoine Simoneau, Justin L Engel, Madhavi Bandi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|April 3, 2022
Associations of Maternal Prenatal Stress and Depressive Symptoms With Childhood Neurobehavioral Outcomes in the ECHO Cohort of the NICHD Fetal Growth Studies: Fetal Growth Velocity as a Potential MediatorVanessa Babineau, Yaneve N Fonge, Emily S Miller, et al.
Nature Chemical Biology|October 30, 2012
Oxygenase-catalyzed ribosome hydroxylation occurs in prokaryotes and humansWei Ge, Alexander Wolf, Tianshu Feng, et al.
Pageof 10